Daniel Silverman, M.D., Ph.D.

University of California, Los Angeles
email: dsilver@ucla.edu

Grants

Patient-Individualized Chemotherapy in Breast Cancer 2001 (Cycle VII)
New Investigator 7KB-0155 $296,994


A non-invasive assay to predict chemotherapy response to 5-fluorouracil using [18F]-5FU and PET
  Periodical: Society of Nuclear Medicine
  Author(s): Townsend A, et al., and Silverman DH
  Yr: 2004 Vol: Nbr: Pgs:
  Associated Grant: Patient-Individualized Chemotherapy in Breast Cancer
 
Predicting chemotherapy response to paclataxel using [18F]-fluoropactataxel and PET.
  Periodical: Society of Nuclear Medicine
  Author(s): Hsueh WA, et al., and Silverman DH
  Yr: 2004 Vol: Nbr: Pgs:
  Associated Grant: Patient-Individualized Chemotherapy in Breast Cancer